The BALANCE Model was originally designed to begin in January 2027 as the Bridge's successor, giving private Part D plans a framework to cover GLP-1 obesity drugs on a sustained basis
The number of slim patches to wear each day will depend on the manufacturer of the weight loss patch
If you want to explore nutritional support during treatment, the GLP-1 Daily Support supplement is designed for that kind of use case
For more on treatment delivery, see our guide to GLP-1 injections explained
Even if employers continue to exclude weight loss drugs from their prescription drug benefits, it is important for them to consider that there may still be off-label (when a doctor prescribes a medication for use other than its approved indication) use of GLP-1s like Ozempic that are also indicated for diabetes
When you're designing a study, mapping out observation points, and allocating resources, timing is everything